(Q42910499)

11 November 2017

title

Serum vasopressin concentrations during orthotopic liver transplantation (English)

1 reference

orthotopic liver transplantation

11 November 2017

0 references

liver transplantation

1 reference

based on heuristic

inferred from title

1 reference

M T Keegan

1

1 reference

11 November 2017

B Gali

2

1 reference

11 November 2017

D R Brown

3

1 reference

11 November 2017

B A Harrison

4

1 reference

11 November 2017

D J Plevak

5

1 reference

11 November 2017

J Y Findlay

6

1 reference

11 November 2017

language of work or name

English

0 references

publication date

1 September 2010

1 reference

Transplantation Proceedings

11 November 2017

published in

1 reference

11 November 2017

volume

42

1 reference

11 November 2017

issue

7

1 reference

11 November 2017

page(s)

2594-2598

1 reference

Vasopressin deficiency contributes to the vasodilation of septic shock

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

The vasopressin system: physiology and clinical strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

Physiology of vasopressin relevant to management of septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

Low-dose vasopressin in the treatment of vasodilatory septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

Beneficial effects of short-term vasopressin infusion during severe septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

Systematic review: terlipressin in acute oesophageal variceal haemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

Low-dose vasopressin restores diuresis both in patients with hepatorenal syndrome and in anuric patients with end-stage heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

New treatments of hepatorenal syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

Surgical advances in liver and bowel transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

7 January 2021

Vasopressin in the ICU.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

Arginine vasopressin as a rescue vasopressor agent in the operating room

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

Employing vasopressin as an adjunct vasopressor in uncontrolled traumatic hemorrhagic shock. Three cases and a brief analysis of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

Vasopressin in hemorrhagic shock.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

Vasopressin during uncontrolled hemorrhagic shock: less bleeding below the diaphragm, more perfusion above

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

Successful treatment of severe anaphylactic shock with vasopressin. Two case reports

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

Vasopressin during spinal anesthesia in a patient with primary pulmonary hypertension treated with intravenous epoprostenol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

Arginine vasopressin in the management of vasodilatory hypotension after cardiac transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

Clinical need for antidiuretic hormone antagonists in cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

Treatment of uncontrolled hemorrhagic shock after liver trauma: fatal effects of fluid resuscitation versus improved outcome after vasopressin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

Vasopressin, but not fluid resuscitation, enhances survival in a liver trauma model with uncontrolled and otherwise lethal hemorrhagic shock in pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

The use of vasopressin bolus to treat refractory hypotension secondary to reperfusion during orthotopic liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

Anterior pituitary function during critical illness and dopamine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.04.051

10.1016/J.TRANSPROCEED.2010.04.051

7 January 2021

Identifiers

DOI

1 reference

11 November 2017

1 reference